EUVIMEDEUVIMED entdecken
Crossref

Adrenocortical Carcinoma: Single Center Experience

Abdullah Sakin, Şaban Seçmeler, Orçun Can, Serdar Arıcı, Çağlayan Geredeli, Nurgul Yaşar, Cumhur Demir, Şener Cihan

European Archives of Medical Research · 2019

DOI: 10.4274/eamr.25744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Medical Research, 2019. Verfasst von Abdullah Sakin und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The prevalence of adrenocortical carcinoma(ACC) is approximately 0.02% of all cancers, and the annual incidence is approximately one to two per million population.Adrenocortical carcinoma is more aggressive, and the prognosis of ACC is poorer in adults than pediatric patients.We aimed to investigate the clinicopathologic characteristics and the factors affecting on the overall survival (OS) in patients with ACC who were followedup, and treated in our hospital in the present study.

Methods

The patients who were treated and followed-up in the oncology clinic between 2006-2018 were retrospectivelly included in the study.The patients who were diagnosed with adrenocortical carcinoma in pathologic evaluation were included in the study.

Results

A total of 10 patients, 5(50%) men, and 5(50%) women, were included in the study.The mean age was 42.4 (range, 18-67) years.Six (60%) patients were in stage 3, and 4 (40%) patients were in stage 4. Eight (80%)patients underwent surgery.The release of glucocorticoid and/or androgen was detected in 6(60%) patients.Recurrence developed in 6(100%) patients, and 7 (70%) patients died during the follow-up.The median survival was 13 months in patients with stage 3 disease, and the median survival was 8 months in patients with stage 4 disease.There was no statistically significant survival difference between the stages (Log rank p: 0.177).The Eastern Cooperative Oncology Group Performance Status (ECOG PS), and performing of surgery were detected as the most significant factors affecting the overall survival (Log rank p: 0.01, Log rank p: 0.02).Conclusıon: We detected the statistically most significant factors for OS as the surgery and ECOG PS in our study.The increase of ECOG PS increased the mortality risk four folds.

Zitieren

APA

Sakin, A., Seçmeler, Ş., Can, O., Arıcı, S., Geredeli, Ç., Yaşar, N., Demir, C., & Cihan, Ş. (2019). Adrenocortical Carcinoma: Single Center Experience. European Archives of Medical Research. https://doi.org/10.4274/eamr.25744

Vancouver

Sakin A, Seçmeler Ş, Can O, Arıcı S, Geredeli Ç, Yaşar N, et al. Adrenocortical Carcinoma: Single Center Experience. European Archives of Medical Research. 2019. doi:10.4274/eamr.25744

BibTeX
@article{Sakin2019,
  author = {Sakin, Abdullah and Seçmeler, Şaban and Can, Orçun and Arıcı, Serdar and Geredeli, Çağlayan and Yaşar, Nurgul and Demir, Cumhur and Cihan, Şener},
  title = {Adrenocortical Carcinoma: Single Center Experience},
  journal = {European Archives of Medical Research},
  year = {2019},
  doi = {10.4274/eamr.25744}
}
Kostenlos starten →